National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
Published Date: 1/7/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a closed meeting on January 30-31, 2025, to review secret contract proposals for vaccine adjuvant development. This affects small businesses competing for government research funding and keeps sensitive info private. The meeting helps decide who gets money to boost vaccine innovation.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Closed SBIR review for vaccine adjuvants
If you are a small business that submitted an SBIR contract proposal under Solicitation PHS 2025-1 (NIH/NIAID 142) for Adjuvant Development for Vaccines, your proposal will be reviewed and evaluated in a closed meeting on January 30–31, 2025, from 9:00 a.m. to 6:00 p.m. This meeting helps decide which small businesses receive contract funding for vaccine adjuvant work.
Confidentiality protection for proposals
The meeting is closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information in contract proposals. If you submitted a proposal, your trade secrets and personal information will be kept private during review.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-10296 — Information Collection Being Reviewed by the Federal Communications Commission Under Delegated Authority
The FCC is asking the public and businesses to share their thoughts on how it collects information to make sure it’s useful and not too much work. They want to cut down on paperwork, especially for small businesses with fewer than 25 employees. If you want to comment, you’ve got until July 21, 2026, so don’t miss your chance to help shape smarter rules!
2026-10299 — Information Collection Being Submitted for Review and Approval to Office of Management and Budget
The Federal Communications Commission (FCC) is asking the public and other agencies to share their thoughts on a paperwork update that aims to make things easier, especially for small businesses with fewer than 25 employees. They want to reduce the hassle of filling out forms and need approval from the Office of Management and Budget (OMB) to keep collecting this info. Comments are open until June 22, 2026, so don’t miss your chance to weigh in!
2026-10238 — Endangered and Threatened Wildlife and Plants; Enhancement of Survival Permit Application; Conservation Benefit Agreement for the Greenback Cutthroat Trout; Colorado
Colorado Parks and Wildlife wants a special permit to help save the greenback cutthroat trout, a rare fish in Colorado. This permit would let them and local landowners work together on projects to protect and grow the trout’s population. The public can share their thoughts by June 22, 2026, as this plan moves forward without big environmental hurdles or extra costs.
2026-10316 — Agency Information Collection Activities: Comment Request
The Social Security Administration wants your thoughts on how they collect info to fix earnings records. If you’ve spotted mistakes in your Social Security earnings, this affects you! They’re asking for comments by June 22, 2026, to make the process easier and less time-consuming—no extra costs involved, just your feedback to help improve things.
2026-10290 — Agency Information Collection Activities Under OMB Review
The Commodity Futures Trading Commission is asking for public feedback on a new information collection plan that could affect traders and companies. They want to make sure the paperwork isn’t too much of a hassle and are open to comments until June 22, 2026. This review helps keep things fair and clear without costing too much time or money.
2026-10284 — Protein Efficiency Ratio Rat Bioassay Studies To Demonstrate That a New Infant Formula Supports the Quality Factor of Sufficient Biological Quality of Protein; Guidance for Industry; Availability
The FDA just released new guidance to help baby formula makers prove their products have good-quality protein using special rat studies. This update affects formula manufacturers and labs, making it easier and clearer to show their formulas meet nutrition standards. The guidance is effective now, helping companies avoid costly mistakes and speed up getting new formulas to market.
Previous / Next Documents
Previous: 2025-00098 — Agency Information Collection Activities; North American Breeding Bird Survey
The U.S. Geological Survey wants to keep collecting info for the North American Breeding Bird Survey and is asking for your thoughts by March 10, 2025. This affects bird watchers and anyone who helps track bird populations, with no new costs but a chance to improve how data is gathered. They’re making sure the process stays easy and useful for everyone involved.
Next: 2025-00100 — National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
The National Institute of Allergy and Infectious Diseases is holding a private meeting on February 6-7, 2025, to review secret vaccine research proposals. This closed session protects sensitive ideas and personal info while deciding which projects get funding. Scientists and companies pitching vaccine ideas will be affected, with important funding choices happening soon.